Biotech & Pharma

UCLA spinout raises $11M to test microbiome-based weight loss therapy

31 sec read6 views0 listens

Bloom Science, a UCLA spinout, secured $11M to develop and test a novel weight loss therapy involving a pill with specific bacteria strains to mimic the ketogenic diet's effects on the gut microbiome. This approach could offer a non-invasive alternative for those seeking weight loss without dietary restrictions, potentially revolutionizing weight management strategies. Content creators focusing on health and wellness should monitor this development as it may provide new content opportunities around innovative weight loss solutions.

Read the full article at Endpoints News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Health & Medicine2 days ago26 sec read

The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

Medicare's GLP-1 discount program, aimed at helping obese patients afford weight loss medications, excludes those with certain medical conditions like sleep apnea, despite these individuals often having the highest need for such drugs. This exclusion...

Ali Nemati

Fitness & WellnessAug 2128 sec read

EP95 | Getting Ready For Sydney

The latest episode of Marathon Talk focuses on the upcoming TCS Sydney Marathon and features an interview with Australian marathon legend Lisa Weightman. This episode is crucial for developers and tech professionals interested in fitness technology, ...

Ali Nemati

Fitness & WellnessAug 2029 sec read

'These Neurons Are an Underlying Problem When It Comes to Narcolepsy'

Researchers have identified a specific group of GABA neurons in the brainstem that act as a switch to induce sleep and suppress wakefulness. This discovery is significant for developers and researchers in the health tech and neuroscience fields as it...

Ali Nemati